Table 1 The median concentration of PFAS (ng/mL) in the serum of the participants.

From: Association between family economic situation and serum PFAS concentration in American adults with hypertension and hyperlipemia

 

N (weighted %)

PFOA

PFNA

PFDA

PFUnDA

PFHxS

PFOS

Overall

 No Diseases

789 (29.6)

1.37

0.5

0.2

0.1

0.9

3.9

 Hypertension

224 (8.4)

1.57

0.5

0.2

0.1

1.2

5.6

 Hyperlipidemia

909 (34.1)

1.57

0.5

0.2

0.1

1.3

5

 Comorbidity

743 (27.9)

1.77

0.7

0.2

0.1

1.5

7.1

 P

 

< 0.05a

< 0.05a

< 0.05b

< 0.05b

< 0.05a

< 0.05c

Gender

 Male

  No Diseases

318 (24.5)

1.67

0.5

0.2

0.1

1.6

6

  P (F)

 

< 0.05

< 0.05

< 0.05

0.40

< 0.05

< 0.05

  Hypertension

107 (8.2)

1.67

0.5

0.2

0.1

1.6

7

  P (F)

 

< 0.05

0.11

0.54

0.28

< 0.05

< 0.05

  Hyperlipidemia

508 (39.2)

1.77

0.6

0.2

0.1

1.6

6.4

  P (F)

 

< 0.05

< 0.05

< 0.05

0.63

< 0.05

< 0.05

  Comorbidity

364 (28.1)

1.97

0.7

0.2

0.1

1.7

8.6

  P (F)

 

< 0.05

0.64

0.53

0.80

< 0.05

< 0.05

 Female

  No Diseases

471 (34.4)

1.07

0.4

0.2

0.1

0.6

2.8

  Hypertension

117 (8.6)

1.47

0.5

0.2

0.07

1

4.7

  Hyperlipidemia

401 (29.3)

1.27

0.5

0.2

0.1

0.8

3.5

  Comorbidity

379 (27.7)

1.57

0.7

0.2

0.1

1.2

5.7

Age

 20–59

  No Diseases

709 (40.1)

1.27

0.4

0.2

0.1

0.8

3.6

  P (OA)

 

< 0.05

< 0.05

< 0.05

< 0.05

< 0.05

< 0.05

  Hypertension

109 (6.2)

1.27

0.5

0.2

0.1

1.1

4.1

  P (OA)

 

< 0.05

< 0.05

0.10

0.97

< 0.05

< 0.05

  Hyperlipidemia

683 (38.6)

1.37

0.5

0.2

0.1

1.2

4.4

  P (OA)

 

< 0.05

< 0.05

< 0.05

< 0.05

< 0.05

< 0.05

  Comorbidity

267 (15.1)

1.47

0.6

0.2

0.1

1.1

5.2

  P (OA)

 

< 0.05

< 0.05

< 0.05

< 0.05

< 0.05

< 0.05

 60+

  No Diseases

80 (8.9)

1.87

0.8

0.2

0.1

1.4

6.35

  Hypertension

115 (12.8)

1.97

0.6

0.2

0.1

1.5

7.6

  Hyperlipidemia

226 (25.2)

1.97

0.7

0.2

0.1

1.7

8.1

  Comorbidity

476 (53.1)

1.935

0.7

0.2

0.1

1.65

8.45

  1. aMeant that there was no statistical difference in concentration between the hypertension and hyperlipidemia groups (P = 0.70–0.86), and there was a difference between any two other groups (P < 0.05). bIndicated that there was no statistical difference in the concentration among the disease-free group, the hypertension group and the hyperlipidemia group (P = 0.48–0.61), and there was a difference between the comorbidity group and the other three groups (P < 0.05). cRepresented a statistical difference in concentration between any two groups (P < 0.05). F represented compared with females. OA represented compared with older adults.
  2. Significant values are in bold.